The Wall Street Journal
The Drug Industry Is Having Its Own DeepSeek Moment — It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S. counterparts.
China’s Firms Are Bleeding Cash—and Vulnerable to Trump’s Trade War — Companies across the country are bleeding cash as they struggle with overcapacity and weak spending in a slumping economy, leaving them vulnerable to tariffs.
The Financial Times
Rep
Subscribe or login to read the rest.
Subscribers get full access to:
- Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
- A weekly curated reading list on China from Andrew Peaple.
- A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our
Subscriptions page for details.
Includes images from Depositphotos.com
